Entrada Therapeutics, Inc.TRDANASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+10.2%
5Y CAGR+50.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+10.2%/yr
Annual compound
5Y CAGR
+50.9%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
7.8x
Strong expansion
Streak
6 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $41.05M | +6.7% |
| 2024 | $38.47M | +19.1% |
| 2023 | $32.29M | +5.4% |
| 2022 | $30.64M | +101.6% |
| 2021 | $15.20M | +190.2% |
| 2020 | $5.24M | +45.2% |
| 2019 | $3.61M | - |